Drugplain

Mometasone Furoate 1 mg/mL

Mometasone Furoate · SOLUTION · Bryant Ranch Prepack

10 Recalls on Record
Plain English

Mometasone furoate is a prescription topical solution applied directly to the skin to reduce inflammation and itching caused by various skin conditions. This medication is a corticosteroid that works by suppressing immune responses in the affected area.

Key Facts

Brand Name
Mometasone Furoate
Generic Name
Mometasone Furoate
NDC Code (Product)
72162-1392
Manufacturer
Bryant Ranch Prepack
Strength
1 mg/mL
Dosage Form
SOLUTION
Route
TOPICAL
Marketing Status
Application #
ANDA077180
Marketing Start
12/11/2008

Recall History

10 Recalls on Record
Class II03/25/2021

Cosette Pharmaceuticals, Inc.

CGMP Deviaitons

TerminatedVoluntary: Firm initiated
Class III07/13/2015

Perrigo Israel Pharmaceuticals

Subpotent drug

TerminatedVoluntary: Firm initiated
Class III01/04/2023

Intersect ENT, Inc.

Failed Dissolution Specification; product did not meet the average 24-hour drug release rate (dissolution) specification stability time point at 9 months.

TerminatedVoluntary: Firm initiated
Class II11/20/2017

Glenmark Pharmaceuticals Inc., USA

CGMP Deviations: Market complaints related to "gritty texture".

TerminatedVoluntary: Firm initiated
Class II11/14/2014

Attix Pharmaceuticals

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

TerminatedVoluntary: Firm initiated
Class III05/28/2024

Organon Llc

Defective Container

OngoingVoluntary: Firm initiated
Class II01/26/2022

CARDINAL HEALTHCARE

CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

TerminatedVoluntary: Firm initiated
Class II07/23/2019

Glenmark Pharmaceuticals Inc., USA

GMP Deviations: Glenmark received complaints stating that mometasone fuorate cream was gritty.

TerminatedVoluntary: Firm initiated
Class III06/16/2022

Glenmark Pharmaceuticals Inc., USA

Defective Container

TerminatedVoluntary: Firm initiated
Class III02/07/2019

ACP Nimble Buyer, Inc.

Labeling: Not Elsewhere Classified. Mometasone Furoate Cream has an NDC typographical error.

TerminatedVoluntary: Firm initiated

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

dyspnoea1,781 reports
asthma1,595 reports
drug ineffective1,532 reports
headache1,452 reports
cough1,215 reports
fatigue1,139 reports
off label use1,089 reports
wheezing990 reports
gastrooesophageal reflux disease979 reports
pruritus939 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

1 INDICATIONS AND USAGE Mometasone furoate cream, 0.1% is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 2 years of age or older. Mometasone furoate cream, 0.1% is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients ≥ 2 years of age. ( 1 )

Dosage & Administration

2 DOSAGE AND ADMINISTRATION Apply a thin film of mometasone furoate cream, 0.1% to the affected skin areas once daily. Mometasone furoate cream, 0.1% may be used in pediatric patients 2 years of age or older. Since safety and efficacy of mometasone furoate cream, 0.1% have not been established in pediatric patients below 2 years of age; use in this age group is not recommended [see Warnings and Precautions ( 5.1 ) and Use in Specific Populations ( 8.4 )]. Therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary [see Warnings and Precautions (5.1)]. Do not use mometasone furoate cream, 0.1% with occlusive dressings unless directed by a physician. Do not apply mometasone furoate cream, 0.1% in the diaper area if the patient still requires diapers or plastic pants, as these garments may constitute occlusive dressing. Avoid contact with eyes. Wash hands after each application. Avoid use on the face, groin, or axillae. Mometasone furoate cream, 0.1% is for topical use only. It is not for oral, ophthalmic, or intravaginal use. • Apply a thin film to the affected skin areas once daily. ( 2 ) • Discontinue

Contraindications

4 CONTRAINDICATIONS Mometasone furoate cream, 0.1% is contraindicated in those patients with a history of hypersensitivity to any of the components in the preparation. Mometasone furoate cream, 0.1% is contraindicated in those patients with a history of hypersensitivity to any of the components in the preparation. ( 4 )

Drug Interactions

7 DRUG INTERACTIONS No drug-drug interaction studies have been conducted with mometasone furoate cream.

Adverse Reactions

6 ADVERSE REACTIONS Most common adverse reactions are: burning, pruritus, and skin atrophy. ( 6 ) To report SUSPECTED ADVERSE REACTIONS, contact Glenmark Pharmaceuticals Inc., USA at 1 (888)721-7115 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice. In controlled clinical trials involving 319 subjects, the incidence of adverse reactions associated with the use of mometasone furoate cream was 1.6%. Reported reactions included burning, pruritus, and skin atrophy. Reports of rosacea associated with the use of mometasone furoate cream have also been received. In controlled clinical trials (n=74) involving pediatric subjects 2 to 12 years of age, the incidence of adverse experiences associated with the use of mometasone furoate cream was approximately 7%. Reported reactions included stinging, pruritus, and furunculosis. The following adverse reactions were reported to be possibly or probab

Frequently Asked Questions

What is Mometasone Furoate used for?

Mometasone furoate is a prescription topical solution applied directly to the skin to reduce inflammation and itching caused by various skin conditions. This medication is a corticosteroid that works by suppressing immune responses in the affected area.

Is Mometasone Furoate a controlled substance?

Mometasone Furoate is not classified as a controlled substance by the DEA.

What is the generic name for Mometasone Furoate?

The generic name for Mometasone Furoate is Mometasone Furoate. There are 6 other brand versions of Mometasone Furoate.

What is the NDC code for Mometasone Furoate 1 mg/mL?

The NDC (National Drug Code) for Mometasone Furoate 1 mg/mL is 72162-1392, listed by Bryant Ranch Prepack.